New Treatment for Hodgkin’s Lymphoma
Consecutive inhibition of telomerase followed by ALT inhibition promotes cell death in Hodgkin's Lymphoma.
Published: 17th October 2022
Patents
- US Provisional Application 63/356,576. Filed 29 June, 2022.
IP Status
- Provisional patent
Seeking
- Development partner
- Commercial partner
- Licensing
- University spin out
- Seeking investment